Midostaurin (Rydapt) for Systemic Mastocytosis (Rydapt) (Last Updated: Apr 20, 2020)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indication
Brand Name:
Rydapt
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Initial